Browse Category

NASDAQ:FGL News 20 November 2025

Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited (NASDAQ: FGL) has become one of the most talked‑about micro‑cap solar stocks in November, as traders pile into the name on the back of a Nasdaq minimum bid‑price warning and a string of ambitious renewable‑energy announcements in Malaysia. As of 20 November 2025, the company sits at a crossroads: it is fighting to keep its Nasdaq listing while simultaneously positioning itself at the center of a multi‑billion‑ringgit solar and green data‑center build‑out. GlobeNewswire+2 FGL stock today: volatile penny name on traders’ radar On 20 November 2025, Founder Group shares are trading around $0.40–$0.42, up strongly from yesterday’s
20 November 2025

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop